HRAS and carcinoma: In particular, the up-regulation of GTPase HRAS is associated with carcinoma [50], while up-regulation of Cortactin and down-regulation of YKT6 and DFFA are related to tumor cell invasiveness [51,52,53] and down-regulation of PPIF/CypD may lead to steatosis [54].